Over-the-counter (OTC) clearing is an issue that remains critical and controversial. As the deadline looms for all standardized OTC derivatives to be cleared by the end of this year, market participants are working hard to ensure that large-scale clearing and trading can take place, according to panelists from CME Group, Murex, and SwapClear taking part in a forum convened by Risk in New York.
Disclaimer: This information was obtained from sources believed to be reliable, but we do not guarantee its accuracy. Neither the information nor any opinion expressed therein constitutes a solicitation of the purchase or sale of any futures or options contracts.
Register for regular updates here and manage your email preferences.